I will answer your second question first. It isn't something we included in the report. To answer your first question about whether or not we looked at small businesses, no, we didn't. It's partly that it would be difficult with the specific data we requested. We didn't really track beyond whether it was paid out of pocket, covered by a private plan, or covered by a public plan.
It's more to the point that we wouldn't be able to track exactly how much those businesses are paying as a share, because sometimes the employees pay half or split it with the employers.
The other big point I would like to make is that we don't exactly know how this pharmacare plan would be rolled out or implemented, exactly how it would to play out. We just had the parameters provided to us by the Standing Committee on Health.